The sustainability of our polymers comes already from the manufacturing process. PHAsT biopolymers are produced via bacterial fermentation with low-to-no carbon footprint using renewable carbon sources. Moreover, the materials themselves are sustainable as they can be disposed exploiting all the options depending on the applications. They are biodegradable in soil and marine environments, home and industrial compostable, recyclable or they can be incinerated with lower carbon emission compared to fossil-based plastics.

PHAsT biopolymers can be used for in vivo applications where high biocompatibility and full biodegradability without toxic byproducts are required, and medical devices and long-term applications where high biocompatibility and durability are the main requirements. Moreover, PHAsT materials offer a full set of disposal options, since they are biodegradable, home and industrial compostable, recyclable, and even incineration results in a much lower carbon emissions compared to the currently used plastics. PHAsT can produce and blend together polyhydroxyalkanoates with a range of different properties from rigid to highly elastomeric behaviour, tunable biodegradability, hence being able to target several applications where different physicochemical properties are required. While no highly elastomeric PHAs are currently available on the market, other companies are able to produce polyhydroxyalkanoates with rigid properties, however, PHAsT is the only one currently able to provide medical grade PHAs for the healthcare and biomedical arena.